InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Discover the complete record of transactions filed by MENDLEIN JOHN, Director. Director active across 1 companies, notably Fate Therapeutics INC. Cumulatively, 5 disclosures have been recorded. Total volume traded: €29k. The latest transaction was filed on 9 June 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
08,650 shares0
Common Stock
SEC:0001209191-22-036350:0·
€28,9141,364 shares@ €21.19790.014% mcap38.4% of flow
Common Stock
SEC:0001209191-22-034554:0·
€46,45731,562 shares@ €1.47190.023% mcap61.6% of flow
Common Stock
SEC:0001209191-22-018188:0·
02,681 shares0
Common Stock
SEC:0000899243-21-022076·
02,681 shares0
Common Stock
SEC:0000899243-21-022076:0·
5 of 5 declarations
About MENDLEIN JOHN
John Mendlein serves as a board member at FATE THERAPEUTICS INC. He contributes to the strategic direction of the company, ensuring that decisions made within the board align with growth objectives. His expertise in biotechnology is a valuable asset.